Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Short-term Investments (2017 - 2022)

Selectis Health's Short-term Investments history spans 6 years, with the latest figure at $24387.0 for Q3 2022.

  • For Q3 2022, Short-term Investments changed 0.0% year-over-year to $24387.0; the TTM value through Sep 2022 reached $24387.0, changed 0.0%, while the annual FY2021 figure was $24387.0, 0.0% changed from the prior year.
  • Short-term Investments for Q3 2022 was $24387.0 at Selectis Health, roughly flat from $24387.0 in the prior quarter.
  • Across five years, Short-term Investments topped out at $307895.0 in Q2 2018 and bottomed at $12134.0 in Q1 2019.
  • The 5-year median for Short-term Investments is $24387.0 (2019), against an average of $73348.6.
  • The largest annual shift saw Short-term Investments skyrocketed 12963.0% in 2018 before it tumbled 95.76% in 2019.
  • A 5-year view of Short-term Investments shows it stood at $162106.0 in 2018, then tumbled by 84.96% to $24387.0 in 2019, then changed by 0.0% to $24387.0 in 2020, then changed by 0.0% to $24387.0 in 2021, then changed by 0.0% to $24387.0 in 2022.
  • Per Business Quant, the three most recent readings for GBCS's Short-term Investments are $24387.0 (Q3 2022), $24387.0 (Q2 2022), and $24387.0 (Q1 2022).